Clinuvel Pharmaceuticals Ltd News

Clinuvel Pharmaceuticals Ltd: Chair's Address

Oct 16 06:13

Clinuvel Pharmaceuticals Ltd: Canadian New Drug Submission for SCENESSE in EPP filed

Oct 1 06:23

Clinuvel Pharmaceuticals Ltd: SCENESSE data to be presented at global porphyria conference

Sep 20 06:22

Clinuvel Pharmaceuticals Ltd: Change of AGM Time of Meeting

Sep 13 07:24

Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Pearl Grimes

Sep 10 13:22

Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Guy van Dievoet

Sep 10 13:22

Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Matthew Pringle

Sep 10 13:21

Clinuvel Pharmaceuticals Ltd: CLINUVEL Investor Webinar

Aug 30 07:48

Clinuvel Pharmaceuticals Ltd: Corporate Governance Statement

Aug 29 07:33

Clinuvel Pharmaceuticals Ltd: Appendix 4G

Aug 29 07:32

Clinuvel Pharmaceuticals Ltd: Dividend/Distribution - CUV

Aug 29 07:30

Clinuvel Pharmaceuticals Ltd: Vitiligo and Operational Update

Aug 21 07:12

Clinuvel Pharmaceuticals Ltd: Annual Results Webinar

Aug 19 07:35

Clinuvel Pharmaceuticals Ltd: Afamelanotide Assists DNA Repair Response Following UVR

Jul 5 07:40

Clinuvel Pharmaceuticals Ltd: SCENESSE European Orphan Drug Designation for VP

Jun 24 06:57

Clinuvel Pharmaceuticals Ltd: afamelanotide in fair-skinned Parkinsons patients

Jun 18 07:27

Clinuvel Pharmaceuticals Ltd: CLINUVEL Newsletter III - June 2024

Jun 11 07:52

Clinuvel Pharmaceuticals Ltd: CLINUVEL withdraws label expansion for adolescent EPP

Jun 3 07:01

Clinuvel Pharmaceuticals Ltd: CLINUVEL and Valentech enter Latin American partnership

May 23 07:57

Clinuvel Pharmaceuticals Ltd: SCENESSE European Orphan Drug Designation for XP

Apr 29 07:24